LHIBRE 4G P/SUSP 50SB PVO FARMAC HISPAN P NETO PRINCIPIO ACTIVO: ACECLOFENACO

Description

PRINCIPIO ACTIVO: ACECLOFENACO

Frasco C/ 120 ml

Concentración: 20 mg/mL (300 mg de natalizumab)

un agente antineoplásico con propiedades esclerosantes

ZALTRAP ZIV 100 MG/4 ML | Frasco Ámpula | 1 UN | Sanofi Aventis

LHIBRE 4G P/SUSP 50SB PVO FARMAC HISPAN P NETO PRINCIPIO ACTIVO: ACECLOFENACO

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy